Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10118
Title: | GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum | Authors: | Nazir, M. Harms, H. Loef, I. Kehraus, S. El Maddah, F. Arslan, İdris. Rempel, V. |
Keywords: | Auxarthron reticulatum GPR18 receptor inhibition marine-derived fungi Onygenaceae amauromine auxarthonoside cannabinoid 1 receptor antagonist G protein coupled receptor G protein coupled receptor 18 G protein coupled receptor 55 piperazinedione plant glycoside triterpene unclassified drug alkaloid cannabinoid 1 receptor cannabinoid 2 receptor cannabinoid receptor antagonist glycoside GPR18 protein, human indole derivative animal cell Article carbon nuclear magnetic resonance CHO cell line controlled study drug receptor binding electrospray mass spectrometry fungus heteronuclear multiple bond correlation IC50 nonhuman nuclear Overhauser effect proton nuclear magnetic resonance receptor blocking sponge (Porifera) structure activity relation animal antagonists and inhibitors Ascomycetes chemical structure chemistry human isolation and purification microbiology Fungi Alkaloids Animals Ascomycota Cannabinoid Receptor Antagonists Glycosides Humans Indoles Molecular Structure Porifera Receptor, Cannabinoid, CB1 Receptor, Cannabinoid, CB2 Receptors, G-Protein-Coupled Triterpenes |
Publisher: | Georg Thieme Verlag | Abstract: | The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1). Recultivation of the fungus to obtain further amounts for more detailed pharmacological evaluation of 1 additionally yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine. Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki0.178µM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74µM). The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptor's potential as a new drug target. Despite the execution of many biological assays, to date, no bioactivity could be found for auxarthonoside (2). © Georg Thieme Verlag KG Stuttgart · New York. | URI: | https://hdl.handle.net/11499/10118 https://doi.org/10.1055/s-0035-1545979 |
ISSN: | 0032-0943 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Teknoloji Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
20
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
19
checked on Nov 21, 2024
Page view(s)
34
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.